Editas Medicine, Inc., Announces Pricing of $50 Million Offering of Common Stock

Foundation Medicine and Collaborators to Present New Data at the American Society of Hematology (ASH) Annual Meeting that Supports Use of FoundationOne®Heme to Advance Personalized Medicine in Blood Cancers

Tango Therapeutics Announces the Addition of Shakti Narayan, Ph.D., J.D. as Chief Business Officer

Agios Appoints Jacqualyn Fouse, Ph.D., to the Board of Directors

Editas Medicine, Inc., Announces Offering of Common Stock